A Multi-center, Randomized, Placebo-Controlled Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Patients With Systemic Lupus Erythematosus
收藏DataCite Commons2026-01-26 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006096/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a multi-center study to evaluate the safety, pharmacokinetics, and efficacy of belimumab intravenous (IV) in pediatric patients 5 to 17 years of age with active systemic lupus erythematosus
提供机构：
Vivli
创建时间：
2020-10-06
